Abstract
The human ether-a-go-go-related gene (hERG) channel is important for repolarization in human myocardium and is a common target for drugs that prolong the QT interval. We studied the effects of two antipsychotics, tiapride and sulpiride, on hERG channels expressed in Xenopus oocytes and also on delayed rectifier K+ currents in guinea pig cardiomyocytes. Neither the amplitude of the hERG outward currents measured at the end of the voltage pulse, nor the amplitude of hERG tail currents, showed any concentration-dependent changes with either tiapride or sulpiride (3~300 µM). However, our findings did show that tiapride increased the potential for half-maximal activation (V1/2) of HERG at 10~300 µM, whereas sulpiride increased the maximum conductance (Gmax) at 3, 10 and 100 µM. In guinea pig ventricular myocytes, bath applications of 100 and 500 µM tiapride at 36℃ blocked rapidly activating delayed rectifier K+ current (IKr) by 40.3% and 70.0%, respectively. Also, sulpiride at 100 and 500 µM blocked IKr by 38.9% and 76.5%, respectively. However, neither tiapride nor sulpiride significantly affected the slowly activating delayed rectifier K+ current (IKs) at the same concentrations. Our findings suggest that the concentrations of the antipsychotics required to evoke a 50% inhibition of IKr are well above the reported therapeutic plasma concentrations of free and total compound.
Keywords: hERG channel, Rapidly-activating delayed rectifier K+ channel, Slowly-activating delayed rectifier K+ channel, Sulpiride, Tiapride
INTRODUCTION
Antipsychotic drugs have been known to cause serious cardiovascular side-effects, including myocarditis, cardiomyopathy and abnormal cardiac rhythm [1]. These drugs share an ability to block the rapid component of the delayed rectifier K+ current (IKr), resulting in a delayed repolarization of the cardiac action potential and prolongation of the QT interval, possibly leading to torsades de pointes [1]. Several epidemiological studies and case-control reports have shown that the rate of sudden death is increased in psychiatric patients taking antipsychotic drugs [2-5].
Tiapride has been classified as a selective dopamine D2-receptor antagonist and is used as an atypical neuroleptic drug for the treatment of agitation, aggressiveness, anxiety, and sleep disorders in elderly patients [6]. It is structurally related to the antipsychotic drug sulpiride, also a selective antagonist of dopamine D2-receptor. Sulpiride is used for the treatment of schizophrenic patients with negative symptoms and as an antiemetic and antidyspeptic [7]. Overdose of sulpiride can cause sinus tachycardia, hypotension, arrhythmia and CNS depression [8]. Tiapride and sulpiride have been reported to induce cardiac ECG changes including prolongation of the corrected QT interval (QTc) and torsades de pointes at therapeutic doses [1,9-12]. It is known that IKr - mediated by an ion channel encoded by the human ether-a-go-go-related gene (hERG) - is important for the termination of the cardiac action potential and determines the shape of the repolarization phase [13]. The aim of the present study was to investigate the possible electrophysiological mechanisms underlying drug-induced QT prolongation. To determine whether hERG channels would be blocked by antipsychotic compounds we evaluated the effects of tiapiride and sulpiride on hERG channels expressed in Xenopus oocytes, as well as the rapid (IKr) and slow (IKs) components of native delayed rectifier K+ currents in guinea pig ventricular myocytes.
METHODS
Expression of hERG in oocytes
hERG (accession no. U04270) cRNA was synthesized by in vitro transcription from 1 µg of linearized cDNA using T7 message machine kits (Ambion, Austin, TX, USA) and stored in 10 mM Tris-HCl (pH 7.4) at -80℃. Stage V~VI oocytes were surgically removed from female Xenopus laevis (Nasco, Modesto, CA, USA) anesthetized with 0.17% tricane methanesulphonate (Sigma, St. Louis, MO, USA). Using fine forceps, the theca and follicle layers were manually removed from the oocytes, and then each oocyte was injected with 40 nl of cRNA (0.1~0.5 µg/µl). The injected oocytes were maintained in a modified Barth's Solution. The modified Barth's Solution contained (mM): 88 NaCl, 1 KCl, 0.4 CaCl2, 0.33 Ca(NO3)2, 1 MgSO4, 2.4 NaHCO3, 10 HEPES (pH 7.4), and 50 µg/ml gentamicin sulphonate. Currents were studied two to seven days after injection. This study was performed according to the Research Guidelines of Kangwon National University IACUC.
Solutions and voltage-clamp recordings from oocytes
Normal Ringer's Solution contained (mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2 and 10 HEPES (pH adjusted to 7.4 with NaOH). Solutions were applied to oocytes by continuous perfusion of the chamber while recording. Solution exchanges were completed within three min, and the hERG currents were recorded 5 min after the solution exchange. Currents were measured at room temperature (20~23℃) with a two-microelectrode voltage clamp amplifier (Warner Instruments, Hamden, CT, USA). Electrodes were filled with 3 M KCl and had a resistance of 2~4 MΩ for voltage-recording electrodes and 0.6~1 M (for current-passing electrodes. Stimulation and data acquisition were controlled with an AD-DA converter (Digidata 1200, Axon Instruments) and pCLAMP software (v 5.1, Axon Instruments). The antipsychotics tiapride, and sulpiride, and other reagents were purchased from Sigma (St. Louis, MO, USA). Stock solutions of tiapride and sulpiride were prepared in distilled water and DMSO, respectively, and added to the external solutions atat the desired suitable concentrations shortly before each experiment.
Pulse protocols and analysis
To obtain concentration-response curves in the presence of tiapride or sulpiride, concentration-dependent inhibition was fitted with the equation:
Itail = Itail·max / [1+(IC50/D)n],
where Itail indicates peak tail currents, Itail·max is the maximum peak tail current, D is the concentration of the small molecule, n is the Hill coefficient, and IC50 is the concentration at which the half-maximal peak tail currents were inhibited.
Solutions and voltage clamp recordings from guinea pig ventricular myocytes
Single ventricular myocytes were isolated from guinea pig hearts using a standard enzymatic technique [14]. Isolated cells were superfused at 36℃ with normal Tyrode's Solution containing (mM): 140 NaCl, 4.4 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, and 10 glucose (pH 7.4 with 4 M NaOH). Inward-rectifier K+ currents were inhibited by the addition of 5 mM CsCl. The patch pipettes (outer diameter 1.5 mm, World Precision Instruments, USA) had resistances of around 1~2 MΩ. The pipette solution for the potassium current measurement contained (mM): 140 KCl, 1 MgCl2, 5 EGTA, 5 MgATP, 2.5 diTris-phosphocreatine and 2.5 disodium phosphocreatine (pH 7.4 with KOH). The 'pipette-to-bath' liquid junction potential was small (-3.5 mV) and was uncorrected. Membrane capacitance (the time integral of the capacitive response to a 10 mV hyperpolarizing pulse from a holding potential of 0 mV, divided by the voltage drop) averaged 121.5±24.5 pF (n=10). Measurements were taken using an Axopatch 200A amplifier (Axon Instruments) and a CV-201 headstage. Voltage-clamp commands were generated using 'WinWCP' (John Dempster, Strathclyde University, UK) or a pClamp (v 5.1, Axon Instruments). The current signals were filtered via a 10 kHz, 8-pole Bessel-type low-pass filter and digitized by an AD-DA converter (Digidata 1200, Axon Instruments) for subsequent analysis (pCLAMP Software 6.0.3.). All chemicals were from Sigma, except for E-4031, which was kindly provided by Eisai Co. (Japan).
Statistical evaluations
All data are expressed as mean±S.E.M. Unpaired or paired Student t tests, or ANOVA were used for statistical comparisons when appropriate, and differences were considered significant at p<0.05.
RESULTS
Effect of tiapride or sulpiride on hERG current in Xenopus oocytes
We examined the effect of tiapride or sulpiride on hERG currents (IHERG) using a Xenopus oocyte expression system. Throughout these experiments, the holding potential was maintained at -70 mV, and tail currents (Itail) were recorded at -60 mV after depolarizing pulses from -50 to +40 mV (Fig. 1 and 2). The amplitude of the outward currents measured at the end of the pulse (IHERG) increased with increasing positive voltage steps, reaching a maximum at -10 mV. The amplitude of IHERG was normalized to the maximum amplitude of the IHERG obtained under the control conditions, and was plotted against the potential of the step depolarization (Relative IHERG, Fig. 1B and 2B). Depolarizing steps to even greater positive values caused a decrease in current, resulting in a negative slope of the I~V curve. The amplitude of IHERG showed no concentration-dependent change with increasing either tiapride or sulpiride concentration. After the depolarizing steps, repolarization to -60 mV induced an outward Itail, which had an amplitude even greater than that of IHERG during depolarization, which is due to rapid recovery from inactivation and a slow deactivation mechanism [15]. The amplitude of Itail did not show concentration-dependent changes with increasing either tiapride or sulpiride concentration (Fig. 1A and 2A). The amplitude of Itail was normalized to the peak amplitude obtained under the control conditions at the maximum depolarization, and was plotted against the potential of the step depolarization (n=3, Fig. 1C; n=4, Fig. 2C). In Fig. 1D and 2D, we plotted the values of V1/2 and Gmax against the concentration of tiapride and sulpiride, respectively. Fig. 1D showed that tiapride increased the values of V1/2 at 10~300 µM (n=3, Fig. 1D). On the contrary, sulpiride increased Gmax at 3, 10, 100 µM (Fig. 2D, n=4, p<0.05).
Fig. 1.
The effect of tiapride on human-ether-a-go-go-related gene (hERG) currents (IHERG) elicited by depolarizing voltage pulses. (A) Superimposed current traces elicited by depolarizing voltage pulses (4 s) in 10 mV steps (upper panel) from a holding potential of -70 mV in the absence of tiapride (control, center panel) and in the presence of 300 µM tiapride (lower panel). (B) Plot of the normalized hERG current measured at the end of depolarizing pulses (IHERG) against the pulse potential in the control and tiapride conditions. The maximal amplitude of the IHERG in the control was given a value of 1. (C) Plot of the normalized tail current measured at its peak just after repolarization. The peak amplitude of the tail current in the absence of the drug was set as 1. Control data were fitted to the Boltzmann Equation, y=1/{1+exp [(-V+V1/2)/dx]}, with V1/2 of -20.8 mV. (D) Plot of the values of V1/2 (open squares) and Gmax (closed circles) against the concentration of tiapride. Symbols with error bars represent mean±S.E.M. (n=3). *p<0.05.
Fig. 2.
The effect of sulpiride on human-ether-a-go-go-related gene (hERG) currents (IHERG) elicited by depolarizing voltage pulses. (A) Superimposed current traces elicited by depolarizing voltage pulses (4 s) in 10 mV steps (upper panel) from a holding potential of -70 mV in the absence of sulpiride (control, center panel) and in the presence of 300 µM sulpiride (lower panel). (B) Plot of the normalized hERG current measured at the end of depolarizing pulses (IHERG) against the pulse potential in the control and tiapride conditions. The maximal amplitude of the IHERG in the control was given a value of 1. (C) Plot of the normalized tail current measured at its peak just after repolarization. The peak amplitude of the tail current in the absence of the drug was set as 1. Control data were fitted to the Boltzmann Equation, y=1/{1+exp[(-V+V1/2)/dx]}, with V1/2 of -25.6 mV. (D) Plot of the values of V1/2 (open squares) and Gmax (closed circles) against the concentration of sulpiride. Symbols with error bars represent mean±S.E.M. (n=4). *p<0.05.
Effect of tiapride or sulpiride on the rapid and slow components of the delayed rectifier K+ currents in guinea pig ventricular myocytes
In further experiments, we tested the effects of tiapride and sulpiride on the rapid and slow components of the delayed rectifiers in guinea pig ventricular myocytes at 36℃, using electrophysiological separation of the currents with a voltage clamp protocol [16] (Fig. 3A, inset; stimulation frequency of 0.03 Hz). Depolarization to +40 mV activated both IKr and IKs, repolarization to -10 mV revealed IKs as a deactivating Itail; subsequent repolarization to -50 mV showed a deactivation in IKr. We confirmed that E-4031 (2 µM), a selective blocker of IKr [17], blocked the rapid component of the delayed rectifier K+ current, but had no effect on IKs (n=4, Fig. 3B). We found that tiapride inhibited IKr in a concentration-dependent manner; 100 µM and 500 µM tiapride inhibited IKr by 40.3±2.0% and 70.0±8.3%, respectively (n=2~3, Fig. 3), suggesting that native IKr is more sensitive to the drug than the HERG channels expressed in Xenopus oocytes. Neither 100 µM nor 500µM tiapride had a significant effect on IKs (n=2~3) under our experimental conditions. These findings indicate that tiapride preferentially blocks the rapid component of the delayed rectifier K+ current but not the slow component, suggesting that tiapride may prolong action potential duration primarily by blocking IKr and not IKs.
Fig. 3.
The effect of tiapride on both slow and rapid components of delayed rectifier K+ currents in guinea pig ventricular myocytes. (A) Representative traces of the rapid component (IKr) and the slow component (IKs) of delayed rectifier K+ channel tail currents before and after treatment with either 100 µM or 500 µM tiapride. (B) A summary of the effects of 100 µM and 500 µM tiapride and 2 µM E-4031 on IKr and IKs tail currents, normalized relative to the control current (n=2~4, *p<0.05). The tail current amplitudes were measured as the difference between the peak outward current and the steady-state current at the end of the repolarizing voltage pulses.
Next we tested the effect of sulpiride on the IKr and IKs components of the delayed rectifier K+ current. As shown in Fig. 4, sulpiride also inhibited IKr in a concentration-dependent manner, with block at 100 µM and 500 µM measured at 21.8±3.8% and 56.6±10.1%, respectively (n=3~4, Fig. 4). This result suggests that the sulpiride sensitivity of native IKr in ventricular myocytes is greater than that of HERG channels in a Xenopus oocyte expression system. Neither 100 µM nor 500 µM sulpiride had a significant effect on IKs (n=2~4) under our experimental conditions. These findings indicate that sulpiride preferentially blocks the rapid component of the delayed rectifier K+ current rather than the slow component, and suggests that sulpiride may prolong action potential duration primarily by blocking IKr and not IKs.
Fig. 4.
The effect of sulpiride on both slow and rapid components of delayed rectifier K+ currents in guinea pig ventricular myocytes. (A) Representative traces of the rapid component (IKr) and the slow component (IKs) of delayed rectifier K+ channel tail currents before and after treatment with either 100 µM or 500 µM sulpiride. (B) A summary of the effects of 100 µM and 500 µM sulpiride and 2 µM E-4031 on IKr and IKs tail currents, normalized relative to the control current (n=3~4, *p<0.05). The tail current amplitudes were measured as the difference between the peak outward current and the steady-state current at the end of the repolarizing voltage pulses.
DISCUSSION
Tiapride and sulpiride are used as antipsychotics based on their ability to inhibit dopamine D2-receptors [6,7]. Cardiovascular disease is common in men with mental disorders; therefore, it is important to examine the potential for medications used to treat psychotic disorder to prolong ventricular repolarization. It is known that drugs that produce only a slight increase in repolarization time (5~10 msec) increase the risk of sudden death may; however, changes of up to 5 msec may also occur in the QTc with placebo treatment alone [18,19]. In case reports examining the effects of therapeutic doses of tiapride and sulpiride on the human QT interval, the QTc increased by 160 msec after tiapride (300 mg) [10] and by 51 msec after sulpiride (150 mg) [20].
The results of this study suggest that tiapride and sulpiride were not potent hERG channel blockers. Both drugs failed to reduce hERG outward currents (measured at the end of the voltage pulse) and hERG tail currents expressed in Xenopus oocytes, although tiapride did increase the values of V1/2 indicating that it may have altered channel activation gating.
Tiapride and sulpiride are relatively hydrophilic benzamide compounds that are mainly excreted unchanged in the urine, with elimination half-lives usually in the range 3~10 h [22]. The therapeutic plasma concentrations of tiapride and sulpiride have been reported to be up to ~1.9 µM (682 ng/ml) and ~2.8 µM (940 ng/ml), respectively [10,20]. When the rate of plasma protein binding is about 40% [21], the free plasma concentration of tiapride and sulpiride may be expected to be up to 1.1 µM and 1.7 µM, respectively. IC50 values for the block of IKr by tiapride and sulpiride were in the 100~500 µM range, which is 30-fold greater than the highest achievable free or total plasma concentration. It has been suggested that drugs with an IC50 at least 30 times greater than the highest achievable free plasma concentration will not cause torsades de pointes, a potentially fatal ventricular tachyarrhythmia [23]. In this context, tiapride and sulpiride were unique from other QTc-prolonging compounds in that they did not produce significant hERG blockade even at 300 µM, which suggests that mechanisms other than hERG channel block could be involved in the ability of tiapride and sulpiride to increase QTc. Also, the difference in the degree of block of between hERG channel and the IKr could be attributed to properties specific to the Xenopus oocyte expression system. Higher extracellular concentrations of drugs such as dofetilide and BRL-32872 were required to block hERG channels expressed in ooctyes [24,25] due to the vitelline membrane and egg yolk [26]. Otherwise, the reconstitution of the regulatory β-subunit MiRP with HERG in native IKr could alter the drug sensitivity of hERG and native IKr channels [27].
Antipsychotics are among the most frequently prescribed medications known to cause QT interval prolongation [28]. Silvestre and Prous reported that the potencies for the hERG channel block were different according to the chemical classes of antipsychotics [29]. Butyrophenones and diphenylbutylpiperidines were most potent hERG channel blockers, all with IC50 values in the nM range. In contrast, substituted bezamides and dibenzoxazepines exhibited hERG-blocking activity with IC50 values in the µM range, while thioxanthenes and phenothiazines exhibited moderate to low potencies for blocking hERG channels. Our results have shown that tiapride was a more potent inhibitor of activation gating than sulpiride; on the other hand sulpiride altered the Gmax of hERG current. Altogether, these findings suggest that different antipsychotics may inhibit hERG via specific mechanisms based on their chemical structure.
Our findings are comparable to those reported by Lee et al. where sulpiride blocked hERG currents with an IC50 value of ~1 mM but did not significantly affect cardiac INa, ICa, IKs or IK1 [30]. Also, Silverstre and Prous reported that sulpiride blocked hERG channels with an IC50 value of >100 µM [29]. On the contrary, sulpiride at 1 and 10 µM inhibited L-type Ca2+ current [31] but did not affect voltage-activated K+ currents in pheochromocytoma (PC12) cells, a rat neuronal cell line [32]. This suggests that sulpiride predominantly blocks the rapid, but not the slow, component of the delayed rectifier K+ current in cardiac cells. Indeed, the PR interval and QRS width of the surface ECG, as well as AH and HV intervals of His bundle electrograms, were unaffected by sulpiride, suggesting that sulpiride may not affect Na+ or Ca2+ channels of the heart in situ [20]. The results of this study, and those of others mentioned above, have shown that sulpiride fails to blocked hERG or IKr at therapeutic concentrations. However, the combination of overdose with other factors such as heart disease or changes in drug metabolism and protein binding may reduce the IC50 value for the sulpiride block of hERG or IKr and thereby increase the possibility of drug-induced QT prolongation.
ACKNOWLEDGEMENTS
This study was supported by the Research Grant from Kangwon National University School of Medicine (KNUSM-10-03).
ABBREVIATIONS
- hERG
human ether-a-go-go-related gene
- V1/2
the potential for half-maximal activation
- Gmax
the maximum conductance
- IKr
the rapidly activating delayed rectifier K+ current
- IKs
the slowly activating delayed rectifier K+ current
- QTc
the corrected QT interval
- IHERG
hERG currents
- Itail
tail currents
- PC12
pheochromocytoma
References
- 1.Stöllberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005;20:243–251. doi: 10.1097/01.yic.0000166405.49473.70. [DOI] [PubMed] [Google Scholar]
- 2.Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, Glasser DB, Morrison MF, Strom BL. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2002;325:1070–1074. doi: 10.1136/bmj.325.7372.1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58:1161–1167. doi: 10.1001/archpsyc.58.12.1161. [DOI] [PubMed] [Google Scholar]
- 4.Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry. 2002;180:515–522. doi: 10.1192/bjp.180.6.515. [DOI] [PubMed] [Google Scholar]
- 5.Straus SM, Bleumink GS, Dieleman JP, van der Lei J, 't Jong GW, Kingma JH, Sturkenboom MC, Stricker BH. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164:1293–1297. doi: 10.1001/archinte.164.12.1293. [DOI] [PubMed] [Google Scholar]
- 6.Steele JW, Faulds D, Sorkin EM. Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation. Drugs Aging. 1993;3:460–478. doi: 10.2165/00002512-199303050-00007. [DOI] [PubMed] [Google Scholar]
- 7.Mucci A, Nolfe G, Maj M. Levosulpiride: a review of its clinical use in psychiatry. Pharmacol Res. 1995;31:95–101. doi: 10.1016/1043-6618(95)80053-0. [DOI] [PubMed] [Google Scholar]
- 8.Capel MM, Colbridge MG, Henry JA. Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol. 2000;3:51–54. doi: 10.1017/S1461145700001760. [DOI] [PubMed] [Google Scholar]
- 9.Huang BH, Hsia CP, Chen CY. Sulpiride induced torsade de pointes. Int J Cardiol. 2007;118:e100–e102. doi: 10.1016/j.ijcard.2007.01.060. [DOI] [PubMed] [Google Scholar]
- 10.Iglesias E, Esteban E, Zabala S, Gascon A. Tiapride-induced torsade de pointes. Am J Med. 2000;109:509. doi: 10.1016/s0002-9343(00)00564-7. [DOI] [PubMed] [Google Scholar]
- 11.Lin CH, Chen MC, Wang SY, Lin CY. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics. J Formos Med Assoc. 2004;103:437–441. [PubMed] [Google Scholar]
- 12.Su KP, Shen WW, Chuang CL, Chen KP, Chen CC. A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol. Schizophr Res. 2003;59:93–94. doi: 10.1016/s0920-9964(01)00336-x. [DOI] [PubMed] [Google Scholar]
- 13.Tie H, Walker BD, Valenzuela SM, Breit SN, Campbell TJ. The Heart of Psychotropic drug therapy. Lancet. 2000;355:1825. doi: 10.1016/s0140-6736(05)73083-x. [DOI] [PubMed] [Google Scholar]
- 14.Choi SY, Koh YS, Jo SH. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine. J Pharmacol Exp Ther. 2005;313:888–895. doi: 10.1124/jpet.104.080853. [DOI] [PubMed] [Google Scholar]
- 15.Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J. 1998;74:230–241. doi: 10.1016/S0006-3495(98)77782-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Heath BM, Terrar DA. Separation of the components of the delayed rectifier potassium current using selective blockers of IKr and IKs in guinea-pig isolated ventricular myocytes. Exp Physiol. 1996;81:587–603. doi: 10.1113/expphysiol.1996.sp003961. [DOI] [PubMed] [Google Scholar]
- 17.Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195–215. doi: 10.1085/jgp.96.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol. 2001;12:411–420. doi: 10.1046/j.1540-8167.2001.00411.x. [DOI] [PubMed] [Google Scholar]
- 19.Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labeling. Drug Saf. 2001;24:323–351. doi: 10.2165/00002018-200124050-00001. [DOI] [PubMed] [Google Scholar]
- 20.Sugiyama A, Satoh Y, Shiina H, Takeda S, Hashimoto K. Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models. J Cardiovasc Pharmacol. 2002;40:235–245. doi: 10.1097/00005344-200208000-00009. [DOI] [PubMed] [Google Scholar]
- 21.Lenhard G, Kieferndorf U, Berner G, Vogtle-Junkert U, Wagener HH. The importance of pharmacokinetic data on sulpiride: results of a bioequivalence study of two sulpiride 200 mg preparations following oral administration. Int J Clin Pharmacol Ther Toxicol. 1991;29:231–237. [PubMed] [Google Scholar]
- 22.Bressolle F, Bres J, Blanchin MD, Gomeni R. Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels. J Pharm Sci. 1984;73:1128–1136. doi: 10.1002/jps.2600730826. [DOI] [PubMed] [Google Scholar]
- 23.Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32–45. doi: 10.1016/s0008-6363(02)00846-5. [DOI] [PubMed] [Google Scholar]
- 24.Kiehn J, Lacerda AE, Wible B, Brown AM. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation. 1996;94:2572–2579. doi: 10.1161/01.cir.94.10.2572. [DOI] [PubMed] [Google Scholar]
- 25.Thomas D, Wendt-Nordahl G, Rockl K, Ficker E, Brown AM, Kiehn J. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. J Pharmacol Exp Ther. 2001;297:753–761. [PubMed] [Google Scholar]
- 26.Madeja M, Musshoff U, Speckmann EJ. Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis. Eur J Neurosci. 1997;9:599–604. doi: 10.1111/j.1460-9568.1997.tb01636.x. [DOI] [PubMed] [Google Scholar]
- 27.Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175–187. doi: 10.1016/s0092-8674(00)80728-x. [DOI] [PubMed] [Google Scholar]
- 28.Curtis LH, Østbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al-Khatib SM, Usdin Yasuda S, Dans PE, Wright A, Califf RM, Woosley RL, Schulman KA. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med. 2003;114:135–141. doi: 10.1016/s0002-9343(02)01455-9. [DOI] [PubMed] [Google Scholar]
- 29.Silvestre JS, Prous JR. Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol. 2007;29:457–465. doi: 10.1358/mf.2007.29.7.1119172. [DOI] [PubMed] [Google Scholar]
- 30.Lee HA, Kim KS, Park SJ, Kim EJ. Cellular mechanism of the QT prolongation induced by sulpiride. Int J Toxicol. 2009;28:207–212. doi: 10.1177/1091581809337261. [DOI] [PubMed] [Google Scholar]
- 31.Ito K, Nakazawa K, Koizumi S, Liu M, Takeuchi K, Hashimoto T, Ohno Y, Inoue K. Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells. Eur J Pharmacol. 1996;314:143–150. doi: 10.1016/s0014-2999(96)00500-6. [DOI] [PubMed] [Google Scholar]
- 32.Nakazawa K, Ito K, Koizumi S, Ohno Y, Inoue K. Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells. Br J Pharmacol. 1995;116:2603–2610. doi: 10.1111/j.1476-5381.1995.tb17214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]




